Jivi Intravenous and Tildrakizumab-asmn
Determining the interaction of Jivi Intravenous and Tildrakizumab-asmn and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Jivi, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Obizur
Synonyms: Jivi
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Jivi Intravenous-Tildrakizumab-asmn Subcutaneous
- Jivi Intravenous-Tilia Fe
- Jivi Intravenous-Tiludronate
- Jivi Intravenous-Timentin
- Jivi Intravenous-Timentin Add-Vantage
- Jivi Intravenous-Timentin Injection
- Tildrakizumab-asmn-Jolessa
- Tildrakizumab-asmn-Jolessa extended-cycle
- Tildrakizumab-asmn-Jolivette
- Tildrakizumab-asmn-Jornay PM
- Tildrakizumab-asmn-Juleber
- Tildrakizumab-asmn-Juluca